The endocrine heart: B-type natriuretic peptide as a diagnostic and therapeutic agent in cardiovascular disease

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Since their discovery 20 years ago, natriuretic peptides have rapidly moved to the forefront in cardiovascular medicine, and have contributed to an appreciation that the heart is an important endocrine organ. Of the natriuretic peptides, brain (B-type) natriuretic peptide (BNP) has proven to be the most clinically useful. Physicians now measure circulating levels of BNP and the N-terminal fragment of its prohormone (N-proBNP) for diagnostic and prognostic assessment in patients with suspected congestive heart failure (CHF), and administer recombinant human BNP as a therapeutic agent for patients with decompensated CHF. This review will highlight the mechanisms of natriuretic peptide regulation, the physiologic actions of BNP, and its utilization in patients with cardiovascular diseases.

Original languageEnglish (US)
Pages (from-to)97-105
Number of pages9
JournalEndocrinologist
Volume13
Issue number2
StatePublished - Mar 2003

Fingerprint

Brain Natriuretic Peptide
Cardiovascular Diseases
Natriuretic Peptides
Heart Failure
Therapeutics
Proxy
Medicine
Physicians

ASJC Scopus subject areas

  • Endocrinology

Cite this

The endocrine heart : B-type natriuretic peptide as a diagnostic and therapeutic agent in cardiovascular disease. / Le, Brian D.; Addo, Tayo A; de Lemos, James A.

In: Endocrinologist, Vol. 13, No. 2, 03.2003, p. 97-105.

Research output: Contribution to journalArticle

@article{adc0db98376d4c7787d8762eb02f5358,
title = "The endocrine heart: B-type natriuretic peptide as a diagnostic and therapeutic agent in cardiovascular disease",
abstract = "Since their discovery 20 years ago, natriuretic peptides have rapidly moved to the forefront in cardiovascular medicine, and have contributed to an appreciation that the heart is an important endocrine organ. Of the natriuretic peptides, brain (B-type) natriuretic peptide (BNP) has proven to be the most clinically useful. Physicians now measure circulating levels of BNP and the N-terminal fragment of its prohormone (N-proBNP) for diagnostic and prognostic assessment in patients with suspected congestive heart failure (CHF), and administer recombinant human BNP as a therapeutic agent for patients with decompensated CHF. This review will highlight the mechanisms of natriuretic peptide regulation, the physiologic actions of BNP, and its utilization in patients with cardiovascular diseases.",
author = "Le, {Brian D.} and Addo, {Tayo A} and {de Lemos}, {James A}",
year = "2003",
month = "3",
language = "English (US)",
volume = "13",
pages = "97--105",
journal = "Endocrinologist",
issn = "1051-2144",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - The endocrine heart

T2 - B-type natriuretic peptide as a diagnostic and therapeutic agent in cardiovascular disease

AU - Le, Brian D.

AU - Addo, Tayo A

AU - de Lemos, James A

PY - 2003/3

Y1 - 2003/3

N2 - Since their discovery 20 years ago, natriuretic peptides have rapidly moved to the forefront in cardiovascular medicine, and have contributed to an appreciation that the heart is an important endocrine organ. Of the natriuretic peptides, brain (B-type) natriuretic peptide (BNP) has proven to be the most clinically useful. Physicians now measure circulating levels of BNP and the N-terminal fragment of its prohormone (N-proBNP) for diagnostic and prognostic assessment in patients with suspected congestive heart failure (CHF), and administer recombinant human BNP as a therapeutic agent for patients with decompensated CHF. This review will highlight the mechanisms of natriuretic peptide regulation, the physiologic actions of BNP, and its utilization in patients with cardiovascular diseases.

AB - Since their discovery 20 years ago, natriuretic peptides have rapidly moved to the forefront in cardiovascular medicine, and have contributed to an appreciation that the heart is an important endocrine organ. Of the natriuretic peptides, brain (B-type) natriuretic peptide (BNP) has proven to be the most clinically useful. Physicians now measure circulating levels of BNP and the N-terminal fragment of its prohormone (N-proBNP) for diagnostic and prognostic assessment in patients with suspected congestive heart failure (CHF), and administer recombinant human BNP as a therapeutic agent for patients with decompensated CHF. This review will highlight the mechanisms of natriuretic peptide regulation, the physiologic actions of BNP, and its utilization in patients with cardiovascular diseases.

UR - http://www.scopus.com/inward/record.url?scp=0038625211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038625211&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0038625211

VL - 13

SP - 97

EP - 105

JO - Endocrinologist

JF - Endocrinologist

SN - 1051-2144

IS - 2

ER -